# Ginkgo Biloba Extract in the Treatment of Schizophrenia

> **NCT05258123** · NA · COMPLETED · sponsor: **Beijing HuiLongGuan Hospital** · enrollment: 100 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Ginkgo Biloba Extract
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT05258123
- **Lead sponsor:** Beijing HuiLongGuan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-15
- **Primary completion:** 2018-06-12
- **Final completion:** 2018-08-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05258123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05258123, "Ginkgo Biloba Extract in the Treatment of Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05258123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*